By mining mutation data from COSMIC and TCGA, we found that RSPO4 also underwent truncating and homozygous point mutations, indicating its loss-of-function effect in cancers and genetic diseases (Table 3, Fig. S1D, Table S5 and S6). Here, RSPO4 is linked to hereditary disease.